Landmark Phase 3 MARIPOSA Study Shows
Early data show an overall survival trend favoring the combination of amivantamab and lazertinib compared to osimertinib; consistent results seen in...
Source: globenewswire.com
Status Scale News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Status Scale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Status Scale Today - Breaking & Trending Today
Updated Findings Spur Excitement In nmCRPC, mHSPC, mCRPC
An increased focus on long-term and genomic analyses on established treatments in prostate cancer have revealed new opportunities for patients across disease states.
Source: onclive.com
How to Save 5 Minutes in Evaluating Patients Post-COVID
Some 'simple' tests are simpler than others
Source: medpagetoday.com
Todos Medical Ltd says 3CL Pharma Ltd subsidiary completes trial design for Tollovid Long COVID clinical study in adults
Todos Medical Ltd. (OTCQB:TOMDF) said its majority-owned subsidiary 3CL Pharma Ltd has finished plans for a proposed safety and efficacy clinical trial for...
Source: proactiveinvestors.com
Todos Medical Completes Trial Design for Tollovid Long COVID Clinical Study in Adults
Press release content from NewMediaWire. The AP news staff was not involved in its creation.
Source: apnews.com